The cardiovascular system in the ageing patient

British Journal of Clinical Pharmacology

Volumn 56, Issue 3, 2003, Pages 254-260

  Moore, A ^c   Mangoni, A A ^a,b   Lyons, D ^d   Jackson, S H D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^d NONE

Author keywords

Ageing; Arteries; Inotropes; Sympathetic nervous system; Veins

Indexed keywords

ACETYLCHOLINE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; DIGOXIN; DOBUTAMINE; DOPAMINE; DOXAZOSIN; GLYCERYL TRINITRATE; HISTAMINE; HORMONE; INOTROPIC AGENT; ISOPRENALINE; NITRIC OXIDE; NORADRENALIN; OUABAIN; PRAZOSIN; TERAZOSIN; CARDIOVASCULAR AGENT;

AGED; AGING; ARTERY BLOOD FLOW; ARTERY COMPLIANCE; ARTERY DISEASE; AUTONOMIC NERVOUS SYSTEM; BLOOD VESSEL REACTIVITY; CAPACITANCE BLOOD VESSEL; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR SYSTEM; DISEASE ASSOCIATION; GERONTOLOGICAL RESEARCH; HEART AFTERLOAD; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; HYPOTENSION; INOTROPISM; ORTHOSTATIC HYPOTENSION; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; REVIEW; SYMPATHETIC TONE; VASCULAR RESISTANCE; ADRENERGIC SYSTEM; ARTERY; CARDIOVASCULAR FUNCTION; COMPLIANCE (PHYSICAL); DRUG EFFECT; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASOCONSTRICTION; VASODILATATION; VEIN;

AGING; ARTERIES; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR AGENTS; CARDIOVASCULAR PHYSIOLOGY; COMPLIANCE; HUMANS; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION; VEINS;

EID: 0042820135     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2003.01876.x     Document Type: Review

References (73)

1. Vallance P. Control of the human cardiovascular system by nitric oxide. J Hum Hypertens 1996; 10: 377-381.
2. Whitney RJ. The measurement of volume changes in human limbs. J Physiol 1953; 121: 1-27.
3. Greenfield ADM, Patterson GC. Reactions of the blood vessels of the human forearm to increases in transmural pressure. J Cardiovasc Pharmacol 1982; 4: 388-392.
4. Collier JG, Nachev C, Robinson BF. A new method for studying the pharmacology of superficial veins in conscious man. Br J Pharmacol 1970; 40: 574P-575P.
5. Franklin SS, Gustin W 4th, Wong ND et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-315.
6. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
7. Blacher J, London GM, Safar ME, Mourad JJ. Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. J Hypertens 1999; 17: 237-244.
8. Avolio A, Jones D, Tafazzoli-Shadpour M. Quantification of alterations in structure and function of elastin in arterial media. Hypertension 1998; 32: 170-175.
9. O'Rourke MF. Pulsatile arterial haemodynamics in hypertension. Aust NZ J Med 1976; 6 (Suppl 2): 40-48.
10. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio A, Cockroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002; 105: 213-217.
11. Dart AM, Kingwell BA. Pulse pressure - a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001; 37: 975-984.
12. Gray GA, Webb DJ. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease. Pharmacol Ther 1996; 72: 109-148.
13. Insel PA. Adrenergic receptors - evolving concepts and clinical implications. New Engl J Med 1996; 334: 580-585.
14. Van Zwieten PA. Adrenergic and cholinergic receptors. In Autonomic failure, a textbook of clinical disorders of the autonomic nervous system, 4th edn, eds Mathias CJ, Bannister R. Oxford: Oxford University Press, 1999; 57-58.
15. Lyons D, Roy S, Patel M, Benjamin N, Swift CG. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci 1997; 93: 519-522.
16. Elliott HL, Sumner DJ, McKean K, Reid JL. Effect of age on the responsiveness of vascular alpha-adrenoceptors in man. J Cardiovasc Pharmacol 1982; 4: 388-392.
17. Lakatta EG. Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans. Circulation 1993; 87: 631-636.
18. Kihara M, Nakasaka Y, Mitsui Y, Takahashi M, Schmelzer JD. Ageing differentially modifies sensitivity of nerve blood flow to vasocontractile agents (endothelin-1, noradrenaline and angiotensin II) in sciatic nerve. Mech Ageing Dev 2000; 114: 5-14.
19. Konishi C, Naito Y, Saito Y, Ohara N, Ono H. Age related differences and roles of endothelial nitric oxide and prostanoids in angiotensin II responses of isolated, perfused arteries and veins of rats. Eur J Pharmacol 1997; 320: 175-181.
20. Zhang XZ, Qiu C, Baylis C. Sensitivity of the segmental renal arterioles to angiotensin II in the aging rat. Mech Ageing Dev 1997; 97: 183-192.
21. Tschudi MR, Luscher TF. Age and hypertension differently affect coronary contractions to endothelin-1, serotonin and angiotensins. Circulation 1995; 91: 2415-2422.
22. Andrawis N, Jones DS, Abernethy DR. Ageing is associated with endothelial dysfunction in the human forearm vasculature. J Am Geriatr Soc 2000; 48: 193-198.
23. Hogikyan RV, Supiano MA. Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol 1994; 266 (5 Part 1): E717-E724.
24. Moncada S, Radomski MW, Palmer RMJ. Endothelium derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37: 2495-2501.
25. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 33: 664-666.
26. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
27. Egashira K, Inou T, Hirooka Y et al. Effects of age on endothelium-dependent vasodilatation of resistance coronary artery by acetylcholine in humans. Circulation 1993; 88: 77-81.
28. Gerhard M, Roddy MA, Creager SJ, Creager MA. Ageing progressively impairs endothelium dependent vasodilatation in forearm resistance vessels of humans. Hypertension 1996; 27: 849-853.
29. Andros E, Detmar-Hanna D, Suteparuk S, Gal S, Gerber JG. The effect of ageing on the pharmacokinetics and pharmacodynamics of prazosin. Eur J Clin Pharmacol 1996; 50: 41-46.
30. Tsujii T. Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Group. Int J Urol 2000; 7: 199-205.
31. Wynne HA, Schofield S. Drug-induced orthostatic hypotension. In Syncope in the older patient: causes, investigations and consequences of syncope and falls, ed Kenny RA. London: Chapman & Hall, 1996; 137-154.
32. Van Zweiten PA. Alpha-adrenoceptor blocking agents in the treatment of hypertension. In Hypertension: pathophysiology, diagnosis and management, 2nd edn. eds Laragh JH, Brenner BM. New York: Raven Press, 1995; 2917-2935.
33. Collier JG, Nachev C, Robinson BF. Effect of catecholamines and other vasoactive substances on superficial hand veins in man. Clin Sci 1972; 43: 455-467.
34. Benjamin N, Collier JG, Webb DJ. Angiotensin II augments sympathetic venoconstriction in man. Clin Sci 1988; 75: 337-340.
35. Olsen H, Lanne T. Reduced venous compliance in lower limbs of ageing humans and its importance for capacitance function. Am J Physiol 1998; 275: H878-H886.
36. Martin SA, Alexieva S, Carruthers SG. The influence of dorsal hand vein responsiveness to norepinephrine. Clin Pharmacol Ther 1986; 40: 257-260.
37. Wilkie FL, Halter JB, Prinz PN et al. Age-related changes in venous catecholamines basally and during epinephrine infusion. J Gerontol 1985; 40: 133-140.
38. Lambert ML, Callow ID, Feng QP, Arnold JM. The effects of age on human venous responsiveness to neuropeptide Y. Br J Clin Pharmacol 1999; 47: 83-89.
39. Eichler HG, Hiremath A, Katsir D, Blaschke TF, Hoffman BB. Absence of age-related changes in venous responsiveness to nitroglycerin in vivo in humans. Clin Pharmacol Ther 1987; 42: 521-524.
40. Gascho JA, Fanelli C, Zelis R. Ageing reduces venous distensibility and the venodilatory response to nitroglycerin in normal subjects. Am J Cardiol 1989; 63: 1267-1270.
41. Dachman WD, Ford GA, Hoffman BB, Blaschke TF. Bradykinin-induced venodilation is not impaired in humans. J Gerontol 1992; 47: M166-M170.
42. Rubin PC, Scott PJ, McLean K, Reid JL. Noradrenaline release and clearance in relation to age and blood pressure in man. Eur J Clin Pharmacol 1982; 12: 121-125.
43. Hoeldtke RD, Cilmi KM. Effects of aging on catecholamine metabolism. J Clin Endocrinol Metab 1985; 60: 479-484.
44. Sundlof G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol 1978; 274: 621-637.
45. Fagius J, Wallin BG. Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade. Clin Auton Res 1993; 3: 201-205.
46. Esler M, Skews H, Leonard P, Jackman G, Bobik A, Korner P. Age-dependence of noradrenaline kinetics in normal subjects. Clin Sci 1981; 60: 217-219.
47. Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993; 21: 498-503.
48. Dinenno FA, Jones pp, Seals DR, Tanaka H. Limb blood flow and vascular conductance are reduced with age in healthy humans: relation to elevations in sympathetic nerve activity and declines in oxygen demand. Circulation 1999; 100: 164-170.
49. Esler MD, Turner AG, Kaye DM et al. Aging effects on human sympathetic neuronal function. Am J Physiol 1995; 268: R278-R285.
50. Weidmann P, Beretta-Piccoli C, Ziegler W, Keusch C, Gluck Z, Reubi F. Age versus urinary sodium for judging renin, aldosterone and catecholamine levels: studies in normal subjects and patients with essential hypertension. Kidney Int 1978; 14: 619-628.
51. Esler M, Kaye D, Thompson J et al. Effects of aging on epinephrine secretion, and on regional release of epinephrine from the human heart. J Clin Endocrinol Metab 1995; 80: 435-442.
52. Davy KP, Seals DR, Tanaka H. Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension 1998; 32: 298-304.
53. Tanaka H, Davy KP, Seals DR. Cardiopulmonary baroreflex inhibition of sympathetic nerve activity is preserved with age in healthy humans. J Physiol 1999; 515: 249-254.
54. Esler M, Hastings J, Lambert G, Kaye D, Jennings G, Seals DR. The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Am J Physiol 2002; 282: R909-R916.
55. Mazzeo RS, Rajkumar C, Jennings G, Esler M. Norepinephrine spillover at rest and during submaximal exercise in young and old subjects. J Appl Physiol 1997; 82: 1869-1874.
56. Francis GS, Goldsmith JR, Levine TB, Olivari MT, Cohn JN. The neurohumeral axis in congestive heart failure. Ann Int Med 1984; 101: 307-307.
57. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73: 913-919.
58. Francis GS, Cohn JN. Cardiac failure and the autonomic nervous system. In Autonomic failure, a textbook of clinical disorders of the autonomic nervous system, 4th edn, eds Mathias CJ, Bannister R. Oxford: Oxford University Press, 1999; 477-486.
59. Newton GE, Packer JD. Acute effects of β1 selective and non-selective β adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure. Circulation 1996; 94: 353-358.
60. Aronow W. Effect of beta blockers on mortality and morbidity in persons treated for congestive heart failure. J Am Ger Soc 2001; 49: 331-333.
61. Abete P, Caccese P, Landino P et al. Role of aging in electrical, mechanical, and coronary modification induced by ouabain and epinine in isolated rate heart. Cardiovasc Res 1994; 28: 358-364.
62. Murphy AM, Gaum WE, Lathrop DA, Hussain AS, Ritschel WA, Kaplan S. Age-related digoxin effects in an intact canine model. Am Heart J 1987; 114: 583-588.
63. Kennedy RH, Seifen E. Aging: ouabain-sensitive 86Rb+ uptake rate and responsiveness to digoxin in rat left atrial muscle. J Pharmacol Exp Ther 1989; 248: 104-110.
64. Katano Y, Kennedy RH, Stemmer PM, Temma K, Akera T. Aging and digitalis sensitivity, of cardiac muscle in rats. Eur J Pharmacol 1985; 113: 167-178.
65. Le Blanc PR, Rakusan K. Effects of age and isoproterenol on the cardiac output and regional blood flow in the rat. Can J Cardiol 1987; 3: 246-250.
66. Turner MJ, Mier CM, Spina RJ, Schechtman KB, Ehsani AA. Effects of age and gender on the cardiovascular responses to isoproterenol. J Gerontol A Biol Sci Med Sci 1999; 54: B393-B400.
67. White M, Leenen FH. Effects of age on cardiovascular responses to adrenaline in man. Br J Clin Pharmacol 1997; 43: 407-414.
68. Kaz'min SH, Dudka SB. Age-related changes in inotropic effects of noradrenaline and acetylcholine on the myocardium of guinea pigs. Fiziol Zh 1992; 38: 11-18.
69. Poller U, Schafers RF, Schmuck S et al. Influence of atropine on the cardiovascular effects of noradrenaline and tyramine in elder volunteers. Naunyn Schmiedebergs Arch Pharmacol 1997; 356: 100-106.
70. Ford GA, James OFW. Effect of 'autonomic blockade' on cardiac β-adrenergic chronotropic responsiveness in healthy young, healthy elderly and endurance-trained elderly subjects. Clin Sci 1994; 87: 297-302.
71. Sorensen EV. Effects of positive inotropic drugs on the frequency of contraction of the isolated atria: influence of dose regimen and age. Pharmacol Toxicol 1990; 67: 69-72.
72. Schwartz JB. Dopaminergic responses in the Fischer 344 rat heart: preserved chronotropic and dromotropic responses with ageing. J Gerontol A Biol Sci Med Sci 1997; 52: M36-M43.
73. Poldermans D, Boersma E, Fioretti PM, van Urk H, Boomsma F, Man in't Veld AM. Cardiac chronotropic responsiveness to beta-adrenoreceptor stimulation is not reduced in the elderly. J Am Coll Cardiol 1995; 25: 995-999.